Goyal Pawan, Srivastava Chhitij, Ojha Bal Krishna, Singh Sunil K, Chandra Anil, Garg R K, Srivastava Swati
Department of Neurosurgery, King George's Medical University, Lucknow, India.
Childs Nerv Syst. 2014 May;30(5):851-7. doi: 10.1007/s00381-014-2371-1. Epub 2014 Feb 4.
This study aims at generating knowledge to understand the conditions in which either of the two procedures (endoscopic third ventriculostomy (ETV) and shunt) are better options and to develop good practice guidelines for the treatment of tubercular meningitis (TBM) hydrocephalus.
This study was conducted on 48 patients in pediatric age group (less than or equal to 18 years) of TBM hydrocephalus. The patients were randomized to one of the cerebrospinal fluid diversion procedures (ETV or shunt). The two procedures were compared for their outcome, both radiologically and clinically.
Twenty-four cases underwent shunt, out of which 13 (68%) cases were successful. Twelve (70.3%) cases belonged to grade 3, while one case was of grade 1. In ETV group, 10 (42%) cases had a successful outcome, out of which 7 (38.8%) cases were in grade 3, while 1 case each belonged to grades 1, 2, and 4. Incidence of ETV failure was more in younger age group, i.e., <2 years (n = 7), while no such correlation with age was found in shunt cases.
Though with the present study it looks like that the relative risk of ETV failure is higher than that for shunt, but the risk becomes progressively lower with time. Therefore, if patients survive the early high-risk period, they could experience a long-term survival advantage devoid of life-long shunt-related complications. Though for definitive comparison, a long-term study is needed.
本研究旨在获取知识,以了解两种手术(内镜下第三脑室造瘘术(ETV)和分流术)在何种情况下是更好的选择,并制定结核性脑膜炎(TBM)脑积水治疗的最佳实践指南。
本研究对48例儿童年龄组(小于或等于18岁)的TBM脑积水患者进行。患者被随机分配至脑脊液分流手术(ETV或分流术)之一。对这两种手术的影像学和临床结果进行比较。
24例接受分流术,其中13例(68%)成功。12例(70.3%)属于3级,1例为1级。在ETV组中,10例(42%)有成功结果,其中7例(38.8%)为3级,1例分别属于1、2和4级。ETV失败发生率在年龄较小的组中更高,即<2岁(n = 7),而分流术病例中未发现与年龄有此类相关性。
尽管从本研究来看,ETV失败的相对风险高于分流术,但随着时间推移该风险逐渐降低。因此,如果患者度过早期高危期,他们可能会获得长期生存优势,且无终身分流相关并发症。不过,为进行明确比较,需要开展长期研究。